BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014;111:61-67. [PMID: 24874482 DOI: 10.1038/bjc.2014.271] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Steel TR, Walsh F, Wieczorek-błauż A, Hanif M, Hartinger CG. Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents. Coordination Chemistry Reviews 2021;439:213890. [DOI: 10.1016/j.ccr.2021.213890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
2 Chai CL, Mátyus P. One size does not fit all: Challenging some dogmas and taboos in drug discovery. Future Medicinal Chemistry 2016;8:29-38. [DOI: 10.4155/fmc.15.167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
3 Bhatt AN, Rai Y, Verma A, Pandey S, Kaushik K, Parmar VS, Arya A, Prasad AK, Dwarakanath BS. Non-Enzymatic Protein Acetylation by 7-Acetoxy-4-Methylcoumarin: Implications in Protein Biochemistry. Protein Pept Lett 2020;27:736-43. [PMID: 32133945 DOI: 10.2174/0929866527666200305143016] [Reference Citation Analysis]
4 Guimarães AG, Scotti L, Scotti MT, Mendonça Júnior FJ, Melo NS, Alves RS, De Lucca Júnior W, Bezerra DP, Gelain DP, Quintans Júnior LJ. Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study. Life Sciences 2014;116:8-15. [DOI: 10.1016/j.lfs.2014.08.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
5 Sankaranarayanan R, Kumar DR, Patel J, Bhat GJ. Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?-The Metabolite Hypothesis. Molecules 2020;25:E2243. [PMID: 32397626 DOI: 10.3390/molecules25092243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Yue W, Wang T, Zachariah E, Lin Y, Yang CS, Xu Q, DiPaola RS, Tan XL. Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Sci Rep 2015;5:13390. [PMID: 26294325 DOI: 10.1038/srep13390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wahle BM, Hawley ET, He Y, Smith AE, Yuan J, Masters AR, Jones DR, Gehlhausen JR, Park SJ, Conway SJ, Clapp DW, Yates CW. Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2. Oncotarget 2018;9:718-25. [PMID: 29416648 DOI: 10.18632/oncotarget.22002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Smeda M, Kij A, Proniewski B, Matyjaszczyk-Gwarda K, Przyborowski K, Jasztal A, Derszniak K, Berkowicz P, Kieronska-Rudek A, Stojak M, Sternak M, Chlopicki S. Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer. PLoS One 2020;15:e0230520. [PMID: 32251451 DOI: 10.1371/journal.pone.0230520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Du ZQ, Zhao JZ, Dong J, Bi JB, Ren YF, Zhang J, Khalid B, Wu Z, Lv Y, Zhang XF, Wu RQ. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study. World J Gastroenterol 2019; 25(28): 3798-3807 [PMID: 31391774 DOI: 10.3748/wjg.v25.i28.3798] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Saraf R, Agah S, Datta A, Jiang X. Drug target ranking for glioblastoma multiforme. BMC Biomed Eng 2021;3:7. [PMID: 33902757 DOI: 10.1186/s42490-021-00052-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Xu XR, Yousef GM, Ni H. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood. 2018;131:1777-1789. [PMID: 29519806 DOI: 10.1182/blood-2017-05-743187] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 22.8] [Reference Citation Analysis]
12 Zhang X, Feng Y, Liu X, Ma J, Li Y, Wang T, Li X. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer. J Cancer Res Clin Oncol 2019;145:1387-403. [PMID: 31037399 DOI: 10.1007/s00432-019-02902-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
13 Culita DC, Dyakova L, Marinescu G, Zhivkova T, Spasov R, Patron L, Alexandrova R, Oprea O. Synthesis, Characterization and Cytotoxic Activity of Co(II), Ni(II), Cu(II), and Zn(II) Complexes with Nonsteroidal Antiinflamatory Drug Isoxicam as Ligand. J Inorg Organomet Polym 2019;29:580-91. [DOI: 10.1007/s10904-018-1033-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest 2015;95:702-17. [DOI: 10.1038/labinvest.2015.49] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
15 Ai G, Dachineni R, Kumar DR, Alfonso LF, Marimuthu S, Bhat GJ. Aspirin inhibits glucose‑6‑phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites. Mol Med Rep 2016;14:1726-32. [PMID: 27356773 DOI: 10.3892/mmr.2016.5449] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
16 Dzeshka MS, Shantsila A, Lip GY. Effects of Aspirin on Endothelial Function and Hypertension. Curr Hypertens Rep 2016;18:83. [PMID: 27787837 DOI: 10.1007/s11906-016-0688-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
17 Grishchenko LA, Parshina LN, Larina LI, Kostyro YA, Trofimov BA. Pd-catalyzed cross-coupling of arabinogalactan propargyl ethers with 5-bromosalicylic acid. Carbohydr Polym 2021;273:118561. [PMID: 34560972 DOI: 10.1016/j.carbpol.2021.118561] [Reference Citation Analysis]
18 Ghazanfari-Sarabi S, Habibi-Rezaei M, Eshraghi-Naeeni R, Moosavi-Movahedi AA. Prevention of haemoglobin glycation by acetylsalicylic acid (ASA): A new view on old mechanism. PLoS One 2019;14:e0214725. [PMID: 30986221 DOI: 10.1371/journal.pone.0214725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Wu D, Zhou B, Yang J, Qiu F, Hu S, Zhan H. Can aspirin use reduce the risk of pancreatic cancer: an updated systematic review and meta-analysis. Journal of Pancreatology 2020;3:201-10. [DOI: 10.1097/jp9.0000000000000063] [Reference Citation Analysis]
20 Nagaraju GP, Bramhachari PV, Raghu G, El-Rayes BF. Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis. Cancer Lett. 2015;366:11-18. [PMID: 26116902 DOI: 10.1016/j.canlet.2015.06.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 9.7] [Reference Citation Analysis]
21 Turanli B, Altay O, Borén J, Turkez H, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Systems biology based drug repositioning for development of cancer therapy. Semin Cancer Biol 2021;68:47-58. [PMID: 31568815 DOI: 10.1016/j.semcancer.2019.09.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
22 Tao DL, Tassi Yunga S, Williams CD, McCarty OJT. Aspirin and antiplatelet treatments in cancer. Blood 2021;137:3201-11. [PMID: 33940597 DOI: 10.1182/blood.2019003977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 López-Lázaro M. Understanding why aspirin prevents cancer and why consuming very hot beverages and foods increases esophageal cancer risk. Controlling the division rates of stem cells is an important strategy to prevent cancer. Oncoscience 2015;2:849-56. [PMID: 26682276 DOI: 10.18632/oncoscience.257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Nunn AVW, Guy GW, Botchway SW, Bell JD. From sunscreens to medicines: Can a dissipation hypothesis explain the beneficial aspects of many plant compounds? Phytother Res 2020;34:1868-88. [PMID: 32166791 DOI: 10.1002/ptr.6654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Schrör K, Rauch BH. Aspirin and lipid mediators in the cardiovascular system. Prostaglandins & Other Lipid Mediators 2015;121:17-23. [DOI: 10.1016/j.prostaglandins.2015.07.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
26 Velema WA, Kool ET. The chemistry and applications of RNA 2'-OH acylation. Nat Rev Chem 2020;4:22-37. [PMID: 32984545 DOI: 10.1038/s41570-019-0147-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
27 Brighenti E, Giannone FA, Fornari F, Onofrillo C, Govoni M, Montanaro L, Treré D, Derenzini M. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Oncotarget 2016;7:63226-41. [PMID: 27557515 DOI: 10.18632/oncotarget.11441] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
28 Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA. Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes Control 2018;29:775-84. [PMID: 29915914 DOI: 10.1007/s10552-018-1049-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, Israel E, Boyce JA, Laidlaw TM. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. Am J Respir Crit Care Med 2019;200:704-11. [PMID: 30978291 DOI: 10.1164/rccm.201809-1755OC] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
30 Sankaranarayanan R, Kumar DR, Altinoz MA, Bhat GJ. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways. Int J Mol Sci 2020;21:E9018. [PMID: 33260951 DOI: 10.3390/ijms21239018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen J, Stark LA. Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus. Biomedicines 2017;5:E43. [PMID: 28718829 DOI: 10.3390/biomedicines5030043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
32 Prescott JA, Cook SJ. Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors. Cells 2018;7:E115. [PMID: 30142927 DOI: 10.3390/cells7090115] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
33 Ballerini P, Contursi A, Bruno A, Mucci M, Tacconelli S, Patrignani P. Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies. Front Pharmacol 2022;13:838079. [DOI: 10.3389/fphar.2022.838079] [Reference Citation Analysis]
34 Mammadova-Bach E, Mangin P, Lanza F, Gachet C. Platelets in cancer. From basic research to therapeutic implications. Hamostaseologie. 2015;35:325-336. [PMID: 26289826 DOI: 10.5482/hamo-14-11-0065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
35 Michel P, Boige V, Andre T, Aparicio T, Bachet JB, Dahan L, Guimbaud R, Lepage C, Manfredi S, Tougeron D, Taieb J, Selves J, Le Malicot K, Di Fiore F, Maillard E. Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK). Dig Liver Dis 2018;50:305-7. [PMID: 29402752 DOI: 10.1016/j.dld.2017.12.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
36 Dawoud M, Attallah KM, Abdelhalim SM, Marzook FA, Abdelgawad MR, Mahmoud AF, Ibrahim IT. Labeling of Aspirin with 99mTc to Obtain a Possible Tumor Imaging Agent. Radiochemistry 2021;63:820-7. [DOI: 10.1134/s106636222106014x] [Reference Citation Analysis]
37 Tewari D, Majumdar D, Vallabhaneni S, Bera AK. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC). Sci Rep 2017;7:45184. [PMID: 28327594 DOI: 10.1038/srep45184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
38 Nounu A, Greenhough A, Heesom KJ, Richmond RC, Zheng J, Weinstein SJ, Albanes D, Baron JA, Hopper JL, Figueiredo JC, Newcomb PA, Lindor NM, Casey G, Platz EA, Le Marchand L, Ulrich CM, Li CI, van Duijnhoven FJB, Gsur A, Campbell PT, Moreno V, Vodicka P, Vodickova L, Brenner H, Chang-Claude J, Hoffmeister M, Sakoda LC, Slattery ML, Schoen RE, Gunter MJ, Castellví-Bel S, Kim HR, Kweon SS, Chan AT, Li L, Zheng W, Bishop DT, Buchanan DD, Giles GG, Gruber SB, Rennert G, Stadler ZK, Harrison TA, Lin Y, Keku TO, Woods MO, Schafmayer C, Van Guelpen B, Gallinger S, Hampel H, Berndt SI, Pharoah PDP, Lindblom A, Wolk A, Wu AH, White E, Peters U, Drew DA, Scherer D, Bermejo JL, Williams AC, Relton CL. A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer. Cancer Epidemiol Biomarkers Prev 2021;30:564-75. [PMID: 33318029 DOI: 10.1158/1055-9965.EPI-20-1176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Belayneh YM, Amare GG, Meharie BG. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review. J Oncol Pharm Pract 2021;27:954-61. [PMID: 33427041 DOI: 10.1177/1078155220984846] [Reference Citation Analysis]
40 Abdolvahabi A, Shi Y, Rhodes NR, Cook NP, Martí AA, Shaw BF. Arresting amyloid with coulomb's law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation. Biophys J 2015;108:1199-212. [PMID: 25762331 DOI: 10.1016/j.bpj.2015.01.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
41 Putri JF, Widodo N, Sakamoto K, Kaul SC, Wadhwa R. Induction of senescence in cancer cells by 5′-Aza-2′-deoxycytidine: Bioinformatics and experimental insights to its targets. Computational Biology and Chemistry 2017;70:49-55. [DOI: 10.1016/j.compbiolchem.2017.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
42 Avagliano A, Granato G, Ruocco MR, Romano V, Belviso I, Carfora A, Montagnani S, Arcucci A. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts. Biomed Res Int 2018;2018:6075403. [PMID: 29967776 DOI: 10.1155/2018/6075403] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 12.5] [Reference Citation Analysis]
43 Thyagarajan A, Saylae J, Sahu RP. Acetylsalicylic acid inhibits the growth of melanoma tumors via SOX2-dependent-PAF-R-independent signaling pathway. Oncotarget 2017;8:49959-72. [PMID: 28636992 DOI: 10.18632/oncotarget.18326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
44 Kočišová E, Sayedová S, Procházka M. Drop coating deposition Raman scattering of selected small molecules of biological importance. J Raman Spectrosc 2020;51:871-4. [DOI: 10.1002/jrs.5840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Cooke NM, Spillane CD, Sheils O, O'Leary J, Kenny D. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion. BMC Cancer 2015;15:627. [PMID: 26353776 DOI: 10.1186/s12885-015-1634-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
46 Liesenfeld DB, Botma A, Habermann N, Toth R, Weigel C, Popanda O, Klika KD, Potter JD, Lampe JW, Ulrich CM. Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. Cancer Epidemiol Biomarkers Prev 2016;25:180-7. [PMID: 26585118 DOI: 10.1158/1055-9965.EPI-15-0697] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
47 Savukaitytė A, Gudoitytė G, Bartnykaitė A, Ugenskienė R, Juozaitytė E. siRNA Knockdown of REDD1 Facilitates Aspirin-Mediated Dephosphorylation of mTORC1 Target 4E-BP1 in MDA-MB-468 Human Breast Cancer Cell Line. Cancer Manag Res 2021;13:1123-33. [PMID: 33574709 DOI: 10.2147/CMAR.S264414] [Reference Citation Analysis]
48 Wall T, Sherwin A, Ma D, Buggy DJ. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth. 2019;123:135-150. [PMID: 31255291 DOI: 10.1016/j.bja.2019.04.062] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 20.0] [Reference Citation Analysis]
49 Smolko L, Smolková R, Samoľová E, Morgan I, Saoud M, Kaluđerović GN. Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity. J Inorg Biochem 2020;210:111160. [PMID: 32717439 DOI: 10.1016/j.jinorgbio.2020.111160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Dachineni R, Kumar DR, Callegari E, Kesharwani SS, Sankaranarayanan R, Seefeldt T, Tummala H, Bhat GJ. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer. Int J Oncol 2017;51:1661-73. [PMID: 29075787 DOI: 10.3892/ijo.2017.4167] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
51 Jiang MJ, Dai JJ, Gu DN, Huang Q, Tian L. Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. Biochim Biophys Acta 2016;1866:163-76. [PMID: 27567928 DOI: 10.1016/j.bbcan.2016.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
52 Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H. Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas. Oncotarget 2018;9:29180-92. [PMID: 30018744 DOI: 10.18632/oncotarget.25650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Hussain MA, Iqbal S, Ercisli S, Hameed A, Tahir MN. Esterification of Salicylic acid with Succinylated Dextran Using ZrOCl2.8H2O over MCM-41: A Novel Strategy to Design Polysaccharide-Based Macromolecular Prodrugs. Arab J Sci Eng 2021;46:5583-91. [DOI: 10.1007/s13369-020-05143-9] [Reference Citation Analysis]
54 Zheng W, Cai X, Xie M, Liang Y, Wang T, Li Z. Structure-Based Identification of a Potent Inhibitor Targeting Stp1-Mediated Virulence Regulation in Staphylococcus aureus. Cell Chem Biol 2016;23:1002-13. [PMID: 27499528 DOI: 10.1016/j.chembiol.2016.06.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
55 Abdelmonsif DA, Sultan AS, El-hadidy WF, Abdallah DM. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Mol Diagn Ther 2018;22:115-27. [DOI: 10.1007/s40291-017-0307-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
56 Pansare K, Mohanty B, Dhotre R, Pettiwala AM, Parab S, Gupta N, Gera P, Gardi N, Dugge R, Sahu P, Alhans R, Kowtal P, Chaudhari P, Sarin R. Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma. Cells 2021;11:123. [PMID: 35011685 DOI: 10.3390/cells11010123] [Reference Citation Analysis]
57 Kaur G, Silakari O. Multiple target-centric strategy to tame inflammation. Future Med Chem 2017;9:1361-76. [PMID: 28771028 DOI: 10.4155/fmc-2017-0050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
58 Panettieri S, Paddibhatla I, Chou J, Rajwani R, Moore RS, Goncharuk T, John G, Govind S. Discovery of aspirin-triggered eicosanoid-like mediators in a Drosophila metainflammation blood tumor model. J Cell Sci 2019;133:jcs236141. [PMID: 31562189 DOI: 10.1242/jcs.236141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
59 Ashraf A, Aman F, Movassaghi S, Zafar A, Kubanik M, Siddiqui WA, Reynisson J, Söhnel T, Jamieson SMF, Hanif M, Hartinger CG. Structural Modifications of the Antiinflammatory Oxicam Scaffold and Preparation of Anticancer Organometallic Compounds. Organometallics 2019;38:361-74. [DOI: 10.1021/acs.organomet.8b00751] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
60 Seewaldt VL. Aspirin and Chemoprevention-Have We Arrived? JAMA Oncol 2018;4:1668-9. [PMID: 30286216 DOI: 10.1001/jamaoncol.2018.4138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
61 Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, Massfelder T, Rathmell WK, Xia M, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Prudhomme KR, Colacci A, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Lowe L, Jensen L, Bisson WH, Kleinstreuer N. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis 2015;36 Suppl 1:S184-202. [PMID: 26106137 DOI: 10.1093/carcin/bgv036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
62 Bilani N, Bahmad H, Abou-Kheir W. Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms. Front Pharmacol 2017;8:145. [PMID: 28377721 DOI: 10.3389/fphar.2017.00145] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
63 Barry EL, Fedirko V, Uppal K, Ma C, Liu K, Mott LA, Peacock JL, Passarelli MN, Baron JA, Jones DP. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Cancer Prev Res (Phila) 2020;13:863-76. [PMID: 32655007 DOI: 10.1158/1940-6207.CAPR-20-0014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Kowalski K. Insight into the Biological Activity of Organometallic Acetylsalicylic Acid (Aspirin) Derivatives. ChemPlusChem 2019;84:403-15. [DOI: 10.1002/cplu.201900086] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ye Y, Wen Y, Zhang Z, He S, Bo X. Drug-Target Interaction Prediction Based on Adversarial Bayesian Personalized Ranking. Biomed Res Int 2021;2021:6690154. [PMID: 33628808 DOI: 10.1155/2021/6690154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Ai G, Dachineni R, Kumar DR, Marimuthu S, Alfonso LF, Bhat GJ. Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53. Tumor Biol 2016;37:6007-16. [DOI: 10.1007/s13277-015-4438-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
67 Wang L, Mai Z, Zhao M, Wang B, Yu S, Wang X, Chen T. Aspirin induces oncosis in tumor cells. Apoptosis 2019;24:758-72. [DOI: 10.1007/s10495-019-01555-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
68 Toimela T, Huttala O, Sabell E, Mannerström M, Sarkanen JR, Ylikomi T, Heinonen T. Intra-laboratory validated human cell-based in vitro vasculogenesis/angiogenesis test with serum-free medium. Reprod Toxicol 2017;70:116-25. [PMID: 27915012 DOI: 10.1016/j.reprotox.2016.11.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
69 Dai SX, Li WX, Li GH, Huang JF. Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin. PeerJ 2016;4:e1791. [PMID: 26989626 DOI: 10.7717/peerj.1791] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
70 Vraneš M, Tot A, Jovanović-šanta S, Karaman M, Dožić S, Tešanović K, Kojić V, Gadžurić S. Toxicity reduction of imidazolium-based ionic liquids by the oxygenation of the alkyl substituent. RSC Adv 2016;6:96289-95. [DOI: 10.1039/c6ra16182k] [Cited by in Crossref: 19] [Article Influence: 3.2] [Reference Citation Analysis]
71 Kirtonia A, Gala K, Fernandes SG, Pandya G, Pandey AK, Sethi G, Khattar E, Garg M. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. Semin Cancer Biol 2021;68:258-78. [PMID: 32380233 DOI: 10.1016/j.semcancer.2020.04.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
72 Akkad S, Serpell CJ. Degradable Polymers and Nanoparticles Built from Salicylic Acid. Macromol Rapid Commun 2018;39:e1800182. [PMID: 29786901 DOI: 10.1002/marc.201800182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Liebow M, Larson MC, Thompson CA, Nowakowski GS, Call TG, Macon WR, Kay NE, Habermann TM, Slager SL, Cerhan JR. Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma. Int J Cancer 2021;149:535-45. [PMID: 33644854 DOI: 10.1002/ijc.33541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Farrugia G, Azzopardi M, Saliba C, Grech G, Gross AS, Pistolic J, Benes V, Vassallo N, Borg J, Madeo F, Eisenberg T, Balzan R. Aspirin impairs acetyl-coenzyme A metabolism in redox-compromised yeast cells. Sci Rep 2019;9:6152. [PMID: 30992471 DOI: 10.1038/s41598-019-39489-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Guo J, Zhu Y, Yu L, Li Y, Guo J, Cai J, Liu L, Wang Z. Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer. PeerJ 2021;9:e11591. [PMID: 34414020 DOI: 10.7717/peerj.11591] [Reference Citation Analysis]
76 Dachineni R, Ai G, Kumar DR, Sadhu SS, Tummala H, Bhat GJ. Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention. Mol Cancer Res 2016;14:241-52. [PMID: 26685215 DOI: 10.1158/1541-7786.MCR-15-0360] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
77 Geiger J, Dalgaard LT. Interplay of mitochondrial metabolism and microRNAs. Cell Mol Life Sci 2017;74:631-46. [PMID: 27563705 DOI: 10.1007/s00018-016-2342-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
78 Loomans-Kropp HA, Pinsky P, Umar A. Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. JAMA Netw Open 2021;4:e2032072. [PMID: 33449095 DOI: 10.1001/jamanetworkopen.2020.32072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Thomas GJ, Herranz P, Cruz SB, Parodi A. Treatment of actinic keratosis through inhibition of cyclooxygenase-2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5. Dermatol Ther 2019;32:e12800. [PMID: 30523664 DOI: 10.1111/dth.12800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
80 Chen Z, Li W, Qiu F, Huang Q, Jiang Z, Ye J, Cheng P, Low C, Guo Y, Yi X, Chen W, Yu Y, Han Y, Wu J, Jin S, Kong D, Huang J. Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer. Theranostics 2018;8:4447-61. [PMID: 30214631 DOI: 10.7150/thno.24284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
81 Lichtenberger LM, Fang D, Bick RJ, Poindexter BJ, Phan T, Bergeron AL, Pradhan S, Dial EJ, Vijayan KV. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1. Cancer Prev Res (Phila) 2017;10:142-52. [PMID: 27998883 DOI: 10.1158/1940-6207.CAPR-16-0241] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
82 Noreen F, Chaber-Ciopinska A, Regula J, Schär P, Truninger K. Longitudinal analysis of healthy colon establishes aspirin as a suppressor of cancer-related epigenetic aging. Clin Epigenetics 2020;12:164. [PMID: 33143725 DOI: 10.1186/s13148-020-00956-9] [Reference Citation Analysis]
83 Burn J, Sheth H. The role of aspirin in preventing colorectal cancer. Br Med Bull 2016;119:17-24. [DOI: 10.1093/bmb/ldw028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
84 Jung YR, Kim EJ, Choi HJ, Park JJ, Kim HS, Lee YJ, Park MJ, Lee M. Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells. Mol Pharmacol 2015;88:708-19. [PMID: 26219912 DOI: 10.1124/mol.115.098616] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
85 Wang S, Li P, Lu SM, Ling ZQ. Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells. Int J Biol Sci 2016;12:746-56. [PMID: 27194951 DOI: 10.7150/ijbs.13988] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
86 Piskovatska V, Strilbytska O, Koliada A, Vaiserman A, Lushchak O. Health Benefits of Anti-aging Drugs. Subcell Biochem 2019;91:339-92. [PMID: 30888659 DOI: 10.1007/978-981-13-3681-2_13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
87 Bens A, Friis S, Dehlendorff C, Jensen M, Ejlertsen B, Kroman N, Cronin-fenton D, Mellemkjær L. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study. Preventive Medicine 2018;116:186-93. [DOI: 10.1016/j.ypmed.2018.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
88 Ai G, Dachineni R, Muley P, Tummala H, Bhat GJ. Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention. Tumour Biol. 2016;37:1727-1738. [PMID: 26314861 DOI: 10.1007/s13277-015-3959-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
89 Sava A, Buron F, Routier S, Panainte A, Bibire N, Constantin SM, Lupașcu FG, Focșa AV, Profire L. Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-oxadiazole-2-thiol Scaffold. Int J Mol Sci 2021;22:7079. [PMID: 34209248 DOI: 10.3390/ijms22137079] [Reference Citation Analysis]
90 Sava A, Buron F, Routier S, Panainte A, Bibire N, Profire L. New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies. Biomed Pharmacother 2021;139:111678. [PMID: 33964802 DOI: 10.1016/j.biopha.2021.111678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Zhao M, Wang T, Hui Z. Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness. Thorac Cancer 2020;11:3117-25. [PMID: 32991066 DOI: 10.1111/1759-7714.13619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Lu G, Tong Z, Ding Y, Liu J, Pan Y, Gao L, Tu J, Wang Y, Liu G, Li W. Aspirin Protects against Acinar Cells Necrosis in Severe Acute Pancreatitis in Mice. Biomed Res Int 2016;2016:6089430. [PMID: 28119929 DOI: 10.1155/2016/6089430] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
93 Radde BN, Alizadeh-Rad N, Price SM, Schultz DJ, Klinge CM. Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells. J Cell Biochem 2016;117:2521-32. [PMID: 26990649 DOI: 10.1002/jcb.25544] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
94 Búdová M, Skořepová E, Jan Čejka. Sodium Aspirin Salts: Crystallization and Characterization. Crystal Growth & Design 2018;18:5287-94. [DOI: 10.1021/acs.cgd.8b00718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Lawrence JR, Baxter GJ, Paterson JR. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots. Med Hypotheses 2016;94:74-6. [PMID: 27515206 DOI: 10.1016/j.mehy.2016.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Qorri B, Harless W, Szewczuk MR. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells. Drug Des Devel Ther 2020;14:4149-67. [PMID: 33116404 DOI: 10.2147/DDDT.S264122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Egorova KS, Seitkalieva MM, Posvyatenko AV, Khrustalev VN, Ananikov VP. Cytotoxic Activity of Salicylic Acid-Containing Drug Models with Ionic and Covalent Binding. ACS Med Chem Lett 2015;6:1099-104. [PMID: 26617961 DOI: 10.1021/acsmedchemlett.5b00258] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
98 Mohammed A, Yarla NS, Madka V, Rao CV. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. Int J Mol Sci 2018;19:E2332. [PMID: 30096840 DOI: 10.3390/ijms19082332] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
99 Santos JMO, Costa AC, Dias TR, Satari S, Costa E Silva MP, da Costa RMG, Medeiros R. Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates. Pharmaceuticals (Basel) 2021;14:1084. [PMID: 34832866 DOI: 10.3390/ph14111084] [Reference Citation Analysis]
100 Biltaji E, Walker B, Au TH, Rivers Z, Ose J, Li CI, Brixner DI, Stenehjem DD, Ulrich CM. Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? Cancer Epidemiol Biomarkers Prev 2021;30:1106-13. [PMID: 33849967 DOI: 10.1158/1055-9965.EPI-19-1580] [Reference Citation Analysis]
101 Mohamed AA, Sadeek SA, Abd El-hamid SM, Zordok WA, Awad HM. Mixed-ligand complexes of tenoxicam drug with some transition metal ions in presence of 2,2′-bipyridine: Synthesis, spectroscopic characterization, thermal analysis, density functional theory and in vitro cytotoxic activity. Journal of Molecular Structure 2019;1197:628-44. [DOI: 10.1016/j.molstruc.2019.07.095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
102 Ahmed K, Shaw HV, Koval A, Katanaev VL. A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers. Cancers (Basel) 2016;8:E66. [PMID: 27429001 DOI: 10.3390/cancers8070066] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
103 Zhang Y, Kong W, Jiang J. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms. Sci China Life Sci 2017;60:601-16. [PMID: 28639101 DOI: 10.1007/s11427-017-9047-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
104 Muendlein A, Kinz E, Gasser K, Leiherer A, Rein P, Saely CH, Grallert H, Peters A, Fraunberger P, Drexel H, Lang AH. Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease. Am J Hematol 2015;90:E17-21. [PMID: 25345590 DOI: 10.1002/ajh.23874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
105 Sakpakdeejaroen I, Somani S, Mullin M, Dufès C. Development of transferrin-bearing vesicles encapsulating aspirin for cancer therapy. J Liposome Res 2020;30:174-81. [PMID: 31060409 DOI: 10.1080/08982104.2019.1614054] [Reference Citation Analysis]
106 Daescu M, Iota M, Serbschi C, Ion AC, Baibarac M. The Influence of UV Light on Photodegradation of Acetylsalicylic Acid. Int J Mol Sci 2021;22:4046. [PMID: 33919943 DOI: 10.3390/ijms22084046] [Reference Citation Analysis]
107 Gebauer L, Nist A, Mernberger M, Stiewe T, Moll R, Stabla K, Klinge U, Mack E, Brendel C, Neubauer A. Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors. Cancers (Basel) 2021;13:4959. [PMID: 34638442 DOI: 10.3390/cancers13194959] [Reference Citation Analysis]
108 Amitay EL, Carr PR, Jansen L, Walter V, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes. J Natl Cancer Inst 2019;111:475-83. [PMID: 30388256 DOI: 10.1093/jnci/djy170] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
109 Wood JN. From plant extract to molecular panacea: a commentary on Stone (1763) 'An account of the success of the bark of the willow in the cure of the agues'. Philos Trans R Soc Lond B Biol Sci 2015;370:20140317. [PMID: 25750237 DOI: 10.1098/rstb.2014.0317] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]